Publication | Open Access

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

AllergyAtopic DermatitisAllergy MedicineModerate-to-severe Atopic DermatitisSkin AllergyClinical DermatologyLong-term ManagementDermatologySclerodermaMedicineLiberty Ad Chronos